Mindfulness-Based Cognitive Therapy Adapted for Older Adults At-Risk for the Chronic Pain-Depression Co-Morbidity; The Quiet Focus Pilot Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to pilot a randomized controlled trial comparing an adaptation of mindfulness-based cognitive therapy to the health enhancement program for chronic pain and depression. The main questions it aims to answer in a later fully powered randomized controlled trial are: * Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life? * Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 120
Healthy Volunteers: f
View:

• Older adult (age ≥ 50)

• All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa

• Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months

• Depressed (PHQ-9 score of 5-14)

• English fluency/literacy

• Ability and willingness to participate via in-person and video

• No change to type or dose of antidepressant medications for at least 6 weeks prior to screening

• Willing to provide informed consent and comply with all aspects of the protocol

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Tony V Pham
tonyvpham@mgh.harvard.edu
617-800-9988
Backup
Tony V Pham
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 60
Treatments
Experimental: Quiet Focus
Active_comparator: Health Enhancement Program
Related Therapeutic Areas
Sponsors
Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov